Sandy Mong

Sandy Mong, MD, is a seasoned leader in biotech, specializing in business development, corporate strategy, and program management. They currently serve as a Venture Partner at Catalys Pacific and have founded Stealth Immunology Newco, where they are the CEO. Previously, they held executive roles at Mariana Oncology, BridgeBio, and CRISPR Therapeutics, and worked as a consultant at McKinsey & Company. Sandy obtained their MD from Harvard Medical School and holds a B.S. in Molecular, Cellular and Developmental Biology from Yale University.